Could a 3-Week radiation course replace 6 weeks for head and neck cancer?
NCT ID NCT07573956
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a standard 6-week radiation course after surgery to a shorter 3-week course for people with head and neck cancer. The goal is to see if the shorter schedule works just as well at preventing cancer from coming back. About 369 participants will be randomly assigned to one of the two radiation plans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radiation therapy
- What this could lead to
- If successful, this could offer a shorter, more convenient radiation schedule (3 weeks instead of 6) for head and neck cancer patients after surgery, potentially with similar cancer control.
- What could go wrong
- This is an early-to-mid stage trial, so results are not yet proven. The shorter schedule may not control cancer as well or could cause different side effects. The study is also limited to patients with specific risk features.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dr. Aman Sharma, Associate Professor, Radiation Oncology, NCI, AIIMS
RECRUITINGJhajjar, Haryana, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new nucleotide analogue boost cancer treatment?
- Can a short course of immunotherapy and radiation shrink head and neck tumors before surgery?
- Can a Two-Drug attack shrink Hard-to-Treat head and neck tumors?
- Could a genetic marker guide future cancer therapies in taiwan?
- Could a cheaper copy of keytruda work just as well against cancer?
- Smart T-Cell engager aims to outsmart tumors in first human test